Analytical Data
-
Gene name
C1orf111
- Application
-
Alternative Names
SPATA46; C1orf111; HSD20; Spermatogenesis-associated Protein 46
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5T0L3
-
Expression Region
1-261aa
-
AA Sequence
MENFSLLSIS GPPISSSALS AFPDIMFSRA TSLPDIAKTA VPTEASSPAQ ALPPQYQSII VRQGIQNTAL SPDCSLGDTQ HGEKLRRNCT IYRPWFSPYS YFVCADKESQ LEAYDFPEVQ QDEGKWDNCL SEDMAENICS SSSSPENTCP REATKKSRHG LDSITSQDIL MASRWHPAQQ NGYKCVACCR MYPTLDFLKS HIKRGFREGF SCKVYYRKLK ALWSKEQKAR LGDRLSSGSC QAFNSPAEHL RQIGGEAYLC L
-
Molecular Weight
55.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf111, also known as Chromosome 1 Open Reading Frame 111, is a gene of considerable interest due to its potential roles in various biological processes and diseases. Emerging studies have highlighted its involvement in cellular mechanisms, particularly those related to the regulation of the cell cycle and apoptosis. Dysregulation of C1orf111 expression has been linked to several pathological conditions, including cancer, where it may influence tumorigenesis through effects on cell proliferation and differentiation. To further understand the functional roles of C1orf111, researchers have focused on generating recombinant proteins that can facilitate the study of its structure, interactions, and biological activities in vitro and in vivo. By producing and characterizing these recombinant proteins, scientists aim to elucidate the mechanistic pathways involving C1orf111 and its potential as a therapeutic target. The exploration of C1orf111, therefore, holds promise not only for advancing fundamental biological knowledge but also for contributing to the development of novel diagnostic and therapeutic strategies in oncology and other related fields.
